Correlation Between SAB Biotherapeutics and Humacyte
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Humacyte, you can compare the effects of market volatilities on SAB Biotherapeutics and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Humacyte.
Diversification Opportunities for SAB Biotherapeutics and Humacyte
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between SAB and Humacyte is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Humacyte go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Humacyte
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 5.26 times more return on investment than Humacyte. However, SAB Biotherapeutics is 5.26 times more volatile than Humacyte. It trades about 0.16 of its potential returns per unit of risk. Humacyte is currently generating about -0.17 per unit of risk. If you would invest 5.00 in SAB Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 1.83 from holding SAB Biotherapeutics or generate 36.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 86.96% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Humacyte
Performance |
| Timeline |
| SAB Biotherapeutics |
| Humacyte |
SAB Biotherapeutics and Humacyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Humacyte
The main advantage of trading using opposite SAB Biotherapeutics and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
| Humacyte vs. Crinetics Pharmaceuticals | Humacyte vs. Viridian Therapeutics | Humacyte vs. Cytokinetics | Humacyte vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |